Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aimed to determine the relationship between vitamin D levels and short stature in children under 2 years of age in Bandung.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Multiple reported designs.

Multiple reported designs

More than one design is explicitly reported; examine the supporting methods.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Methods: Conducted as part of the ALG Grant research entitled ‘The Role of Vitamin D in Reducing Maternal and Infant Mortality Rates Across Bandung Regency’, this case-control study included 221 children, of whom 46.1% were below average height.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Association Between Vitamin D Levels and Developmental Status in Short-Stature Children

Multiple reported designs · Children · 2024

Original publication title

Association Between Vitamin D Levels and Developmental Status in Short-Stature Children

Mia Milanti Dewi; Akhmad Imron; Nelly Amalia Risan; Grace Mediana Purnami; Raden Tina Dewi Judistiani; Budi Setiabudiawan

© 2024 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Short stature remains a problem in the Bandung district of Indonesia. Although vitamin D levels do not affect height and developmental deviations, short children are more likely to be underweight and wasted, with a higher incidence of developmental deviations. It should be noted that one of the limitations of this study is that it did not analyze other factors affecting growth or children experiencing developmental deviations such as parenting, diet, genetic factors, and other nutritional elements such as calcium and phosphorus.

Therefore, further research is warranted on the relationship between vitamin D and short stature and developmental deviations.

An extract from the source publication. Read it in context.

At a glance

Study methods

What methods does the paper describe?

This prospective cross-sectional study was conducted to evaluate the role of vitamin D in the developmental delays of children under two years of age with a history of stunted growth in Bandung Regency, West Java, Indonesia. The study targeted participants from the ALG research grant titled “The Role of Vitamin D in Reducing Maternal and Infant Mortality Rates Across Bandung Regency”. Children under 2 years of age with a height-for-age z-score (HAZ) < −2SD based on the WHO CGS curve were included.

Exclusion criteria included abnormal delivery processes, prematurity, low birth weight, history of seizures, multiple congenital anomalies, syndromic conditions, or chronic diseases and congenital anomalies that could affect growth and development, such as congenital heart defects and neurological disorders. Developmental status was assessed using the Indonesian standardized Prescreen Development Questionnaire (PSDQ), categorizing results as normal or abnormal. Ethical approval was obtained from the Research Ethics Committee of the Faculty of Medicine, Universitas Padjadjaran.

Serum samples were collected and analyzed to measure vitamin D levels using enzyme-linked immunosorbent assay (ELISA) kits. The stored biological samples, initially collected during the ALG study, were maintained at −80 °C. Vitamin D levels were categorized as deficient (<20 ng/mL), insufficient (21 to 29 ng/mL), or sufficient (>30 ng/mL). Developmental assessments were conducted in conjunction with laboratory analyses performed at the Clinical Pathology Laboratory of Dr. Hasan Sadikin General Hospital, Bandung.

The measurement of 25-hydroxyvitamin D [25(OH)D] was performed using the Euroimmun ELISA kit (Euroimmun AG, Lübeck, Germany). Serum samples were processed according to the manufacturer’s protocol, and absorbance was read at 405 nm using an ELISA reader (BioTek Instruments, Winooski, VT, USA). Sample size calculations were based on a 95% confidence level and 80% statistical power, resulting in a required minimum of 30 participants per group.

Before conducting statistical analyses, the normality of the data was assessed using the Shapiro: Wilk test to determine the appropriateness of parametric or non-parametric tests. Based on the results, the data in this study were not normally distributed. Descriptive statistics were used to summarize nutritional status and the prevalence of short stature. Comparisons of vitamin D levels between groups were made using the independent t-test for normally distributed data or the Mann: Whitney U-test for non-normally distributed data. Logistic regression was employed to assess the association between short stature and developmental deviations, with results expressed as odds ratios (ORs).

A p-value of <0.05 was considered statistically significant. All analyses were performed using SPSS version 24.

Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods

Abstract: What background does the paper provide?

The first two years of life are crucial for child growth and development, and short stature is a common issue influenced by nutritional deficiencies. This study aimed to determine the relationship between vitamin D levels and short stature in children under 2 years of age in Bandung.

Source: Background:

Introductions

According to the World Health Organization (WHO) Child Growth Standards (CGS), short stature is identified when children are −2 standard deviations (SDs) or more below the height for their chronological age or less than the third percentile [1]. Stunting, on the other hand, is defined as a condition resulting from chronic malnutrition that leads to impaired linear growth and development, typically measured in children under the age of 5 years [2]. Although both terms involve height, stunting emphasizes the nutritional and developmental context, while short stature is more general and includes other possible causes such as genetic or hormonal factors.

Globally, approximately 162 million children under the age of 5 have short stature [2]. In Indonesia, this prevalence in 2022 was 21.6% based on data from the Indonesian Nutrition Status Survey (SSGI), with an incidence of 25.0% in the Bandung district, ranking fifth in West Java [3]. In working towards achieving the goals of sustainable development, the Indonesian government is working to reduce these figures [2,4,5,6,7].

The short stature that occurs in the first 1000 days of life is caused by various factors, including micronutrient deficiencies such as vitamin D [1,4]. While micronutrient deficiencies such as vitamin D have gained attention as contributors, other factors: such as chronic infections, maternal malnutrition, low birth weight, and suboptimal feeding practices: also play significant roles in impairing linear growth [1,4,5,6]. Socio-economic disparities further compound these issues, limiting access to adequate healthcare and nutrition.

Vitamin D is a fat-soluble micronutrient that functions in the intestinal absorption of calcium and is believed to play a role in the growth of children. Vitamin D deficiency can have short-term and long-term effects. Vitamin D can affect the nervous system, and it has a role in the skeletal system. Vitamin D plays a role in brain health from the womb to old age [7]. Vitamin D receptors and 1α hydroxylase are located in neuronal and glial cells, in the nucleus and cytoplasm, and in the cingulate gyrus, caudate, putamen, and substantia nigra [8].

In vitro studies have shown that vitamin D has various actions on oligodendrocytes, astrocytes, microglia, and neuronal cells [8]. Vitamin D-deficient pregnancies can lead to premature birth, low birth weight, and hypoxic brain injury [9].

The prevalence of vitamin D deficiency in Asia is approximately 70%, varying between 6 and 70% in Southeast Asia, >50% in Indonesia, and 47 to 75% in Malaysia [7,8,9,10]. Children (neonates, preschool age) are often more at risk of vitamin D deficiency than adults [9,10,11,12]. The clinical manifestations of vitamin D deficiency are highly variable and even unknown [13,14,15,16,17,18,19,20].

Despite the potential link between vitamin D deficiency and short stature, findings across studies remain inconsistent. While research in Ecuador identified an association between low vitamin D levels and short stature in children aged 6 to 36 months, studies in Bangladesh found no significant differences in vitamin D levels among children with and without short stature [21,22,23,24]. These discrepancies underscore the need for further exploration of the multifactorial etiology of short stature and the role of vitamin D in developmental deviations.

Additionally, delays in developmental milestones, frequently seen in vitamin D-deficient children, may serve as early warning signs that require timely intervention.

Source: 1. Introductions Source: 1. Introductions Source: 1. Introductions Source: 1. Introductions Source: 1. Introductions

Discussion

The study identified 102/221 (46.1%) children of short stature with mothers with lower education levels than those of children of normal height. This is similar to a study that revealed that maternal education was correlated with children of short stature in Indonesia [6]. Thus, more effort is needed from the government to improve education for mothers.

Anthropometric measures of short children revealed some underweight, severely underweight, and stunted children. Macronutrient and micronutrient deficiencies leading to lower body weight may also negatively impact height. A study in Malaysia found that 78.6% of children under 5 years of age were underweight. This can be influenced by lack of parental education, maternal nutrition, number of children, poverty, access to health facilities, and differences in conditions between cities and districts [25,26,27,28,29,30].

Vitamin D is a fat-soluble micronutrient that functions in the intestinal absorption of calcium and is believed to play a role in the growth of children. Vitamin D deficiency has been widely reported worldwide; however, the trends are inconsistent. Research in Bangladesh did not show differences in vitamin D levels in children with or without short stature [21]. However, vitamin D was associated with short stature in children aged 6 to 36 months in Ecuador [22].

Meanwhile, in India, vitamin D supplementation in children with short strides in India increased child growth [22,23].

In our study, there were no differences in vitamin D levels in both groups. However, vitamin D deficiency and insufficiency were found. Although Indonesia has sun exposure that provides sufficient vitamin D, some children experience vitamin D deficiency. Vitamin D exposure must be increased through outdoor play between 10:00 and 13:00 without the use of head covers or sunscreen and allowing more limbs to be exposed to sunlight.

Vitamin D deficiency can have short-term and long-term effects. Vitamin D can affect the nervous system and its role in the skeletal system. Vitamin D plays a role in brain health from the womb to old age [31]. Vitamin D receptors and 1α hydroxylase are located in neuronal and glial cells, in the nucleus and cytoplasm, and in the cingulate gyrus, caudate, putamen, and substantia nigra [30]. In vitro studies have shown that vitamin D has various actions on oligodendrocytes, astrocytes, microglia, and neuronal cells [32].

Vitamin D-deficient pregnancies can lead to premature birth, low birth weight, and hypoxic brain injury [32].

The biological pathways of vitamin D demonstrate several functions in the central nervous system, such as increasing brain cell differentiation, neurotrophin expression, neurotransmitter synthesis, intracellular calcium signaling, and gene/protein expression related to neuron structure. Research in rats born with vitamin D deficiency has shown anatomical changes in the brain, with an expanded cortex area (30%) and decreased ventricular volume, indicating a distortion in early brain development [31].

According to the recommendations of the American Academy of Pediatrics (AAP), developmental screening should be performed regularly, especially at the ages of 9, 18, and 30 months [33,34]. The PSDQ developed in Indonesia has good sensitivity and specificity and was therefore used to link short stature and vitamin D levels.

This study showed that developmental deviations were more prevalent among short children (95.1% vs. 78.2%, p < 0.001). There was no difference in vitamin D in the development deviation group. The relationship between vitamin D and developmental deviations has been studied, but the results are inconsistent. A delay in developmental milestones may be one of the early symptoms that accompany vitamin D deficiency [35]. Fetal vitamin D can affect brain development, as determined by the use of ASQ at 6 months, 12 months, and 24 months of age [26].

Vitamin D administration is also positively associated with temperament, language, and behavior but negatively associated with cognitive and motor impairment [21]. Vitamin D deficiency during the first trimester increases the risk of motor delays by 1 year of age [27]. On the other hand, growth or development in children with vitamin D deficiency has not shown clear differences [28]. In this study, logistic regression analysis showed that short children have a 5.46 times higher risk of developmental deviations.

Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion

Results

A total of 221 children, consisting of 102 (46.2%) with short stature and 119 (53.8%) with normal stature, participated in this study. The characteristics of the subjects are shown in Table 1.

The median age of the short-stature group was significantly higher than that of the normal-stature group (19 months vs. 14 months, p < 0.001). The sex distribution in both groups was predominantly male. Mothers of short-stature children mainly had an education level of elementary or junior high school, while those of normal-stature children predominantly had a high school education or higher. Short-stature children were classified as underweight (21.6%), severely underweight (29.4%), or normal weight (49.0%), compared to normal-stature children, who were predominantly normal weight (91.6%), with only 7.6% underweight and 0.8% severely underweight.

Based on height-to-weight ratio, 12.7% and 10.8% of short-stature children were wasted and severely wasted, respectively, while 76.5% had normal ratios. In contrast, 87.4% of normal-stature children had normal ratios, with 10.1% wasted and 2.5% severely wasted. Head circumference was similar across groups.

Table 2 shows no significant differences in vitamin D levels (median 28.8 vs. 28.8, p = 0.555) or median age (17 vs. 12 months, p = 0.067) between short: and normal-stature children. Nutritional status based on BB/U of children with PSDQ deviation in short children included 15.8% underweight, 15.8% severely underweight, and 68.4% normal, compared to 93.5% normal in children of normal stature, with only 3.2% underweight and severely underweight. Height-for-age ratios showed 22.2% stunted, 29.9% severely stunted, and 48.9% normal among short children, while normal PSDQ children had 83.9% normal, 12.9% stunted, and 3.2% severely stunted.

PSDQ screening gave body weight and head circumference similar to age.

Table 3 shows higher deviations in children with short stature than in children with normal stature (95.1% vs. 78.2%, p < 0.001). However, there was no difference in vitamin D levels between children with different PSDQ scores (median 28.8 vs. 29.9, p = 0.4313). Likewise, there was no difference in the proportion of children who experienced vitamin D deficiency, insufficiency, or normal levels (86.7% vs. 86.2% vs. 85.6%, p = 0.985).

The logistic regression analysis in Table 4 showed that children with short stature have an increased risk of deviations of 5.46 times compared to those with normal stature. However, vitamin D had no effect on the incidence of PSDQ deviations.

Table 1

Characteristics of short and normal stature children.

VariableShort Stature
n = 102
Normal Stature
n = 119
p
Age (Month)
Median (IQR)19 (15 to 22)14 (9 to 20)<0.001 a*
Sex
Male61 (59.8)63 (52.9)0.305 b
Female41 (40.2)56 (47.1)
Mother’s Education
Elementary41 (40.2)31 (26.1)0.010 b*
Junior high school43 (42.2)47 (39.5)
Senior high school18 (17.6)41 (34.5)
Mother’s Occupation
Housewife90 (88.2)111 (93.3)0.193 b
Working12 (11.8)8 (6.7)
Socio-economic status
Minimum wage5 (4.9)5 (4.2)0.590 b
Below 87 (85.3)97 (81.5)
Above10 (9.8)17 (14.3)
Body weight/age
Normal50 (49.0)109 (91.6)<0.001 b*
Underweight22 (21.6)9 (7.6)
Severely underweight30 (29.4)1 (0.8)
Nutritional Status (weight/height)
Normal78 (76.5)104 (87.4)0.029 b*
Wasted13 (12.7)12 (10.1)
Severely wasted11 (10.8)3 (2.5)
Head Circumference
Normal75 (73.5)84 (70.6)0.200 b
Microcephaly23 (22.5)23 (19.3)
Macrocephaly4 (3.9)12 (10.1)

Note: a Mann: Whitney test, b Chi-square test, * significant difference.

Table 2

Differences in vitamin D levels between children of short stature and normal height.

VariableShort Stature
n = 102
Normal Stature
n = 119
p
Vitamin D
Median (IQR)28.8 (23.6 to 32.5)28.8 (22.8 to 36.2)0.555 a
Vitamin D
Deficiency12 (11.8)18 (15.1)0.647 b
Insufficiency43 (42.1)44 (37.0)
Normal47 (46.1)57 (47.9)

Note: a Mann: Whitney test, b Chi-square test.

Table 3

Characteristics of Prescreen Development Questionnaire (PSDQ) for child development.

VariablePSDQ p
Deviation/Doubtful
n = 190
Normal
n = 30
Age (month)
Median (IQR)17 (12 to 21)12 (9 to 20)0.067 a
Sex
Male106 (55.8)18 (58.1)0.813 b
Female84 (44.2)13 (41.9)
Mother’s Education
Elementary school65 (34.2)7 (22.6)0.213 b
Junior high school78 (41.1)12 (38.7)
Senior high school47 (24.7)12 (38.7)
Mother’s Occupation
Housewife171 (90.0)30 (96.8)0.322 b
Working19 (10.0)1 (3.2)
Socio-economic status
According to regional minimum wage9 (4.8)1 (3.2)0.160 b
Below regional minimum wage161 (84.7)23 (74.2)
Above regional minimum wage20 (10.5)7 (22.6)
Body Weight/Age
Normal130 (68.4)29 (93.5)0.015 b*
Underweight30 (15.8)1 (3.2)
Severely underweight30 (15.8)1 (3.2)
Height/Age
Normal93 (48.9)26 (83.9)0.001 b*
Stunted42 (22.2)4 (12.9)
Severely stunted55 (29.9)1 (3.2)
Nutrition State BB/TB
Normal153 (80.6)29 (93.6)0.204 b
Wasted24 (12.6)1 (3.2)
Severely wasted13 (6.8)1 (3.2)
Head Circumference/Age
Normal135 (71.1)24 (77.4)0.610 b
Microsefal40 (21.0)6 (19.4)
Macrosefal15 (7.9)1 (3.2)

Note: a Mann: Whitney test, b Chi-square test, * significant difference.

Table 4

Relationship between short stature, vitamin D, and child development according to logistic regression analysis.

VariableTotalPSDQ p UnivariateMultivariate
n = 221Deviation/DoubtfulNormalOR (95% CI)Nilai pAdjusted OR
(95% CI)
p
n = 190n = 31
Stature
Short10297 (95.1)5 (4.9)<0.001 b*5.42 (2.00 to 14.72)0.001 *5.46 (2.01 to 14.84)0.001 *
Normal11993 (78.2)26 (21.8) 1 1
Vitamin D
Median (IQR) 28.8 (22.975 to 34.6)29.9 (25.3 to 35.3)0.413 a
Vitamin D
Deficiency3026 (86.7)4 (13.3)0.985 b1.10 (0.34 to 3.59)0.881.19 (0.35 to 4.01)0.784
Insufficiency8775 (86.2)12 (13.8) 1.05 (0.46 to 2.39)0.9010.99 (0.43 to 2.31)0.983
Normal10489 (85.6)15 (14.4) 1 1

Note: a Mann: Whitney test, b Chi-square test, * significant difference. Dependent variable: Development deviation, OR = odds ratio, CI = confidence interval.

Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results

Conclusions

Short stature remains a problem in the Bandung district of Indonesia. Although vitamin D levels do not affect height and developmental deviations, short children are more likely to be underweight and wasted, with a higher incidence of developmental deviations. It should be noted that one of the limitations of this study is that it did not analyze other factors affecting growth or children experiencing developmental deviations such as parenting, diet, genetic factors, and other nutritional elements such as calcium and phosphorus.

Therefore, further research is warranted on the relationship between vitamin D and short stature and developmental deviations.

Source: 5. Conclusions
Authors’ abstract

Background:

The first two years of life are crucial for child growth and development, and short stature is a common issue influenced by nutritional deficiencies. This study aimed to determine the relationship between vitamin D levels and short stature in children under 2 years of age in Bandung.

Methods:

Conducted as part of the ALG Grant research entitled ‘The Role of Vitamin D in Reducing Maternal and Infant Mortality Rates Across Bandung Regency’, this case-control study included 221 children, of whom 46.1% were below average height.

Results:

Nutritional status played a significant role, with short stature being associated with underweight (21.6%), severely underweight (29.4%), wasted (12.7%), and severely wasted (10.8%) conditions. However, the analysis revealed no significant difference in vitamin D levels between children with short stature and those with normal stature (median 28.8 vs. 28.8, p = 0.555). Logistic regression showed that short stature increased the risk of developmental deviations by 5.46 times compared to normal stature.

Conclusions:

While short stature remains a concern in Bandung, vitamin D levels do not appear to influence the incidence of short stature or developmental deviations in this population.

Read the full paper

1. Introductions

According to the World Health Organization (WHO) Child Growth Standards (CGS), short stature is identified when children are −2 standard deviations (SDs) or more below the height for their chronological age or less than the third percentile [1]. Stunting, on the other hand, is defined as a condition resulting from chronic malnutrition that leads to impaired linear growth and development, typically measured in children under the age of 5 years [2]. Although both terms involve height, stunting emphasizes the nutritional and developmental context, while short stature is more general and includes other possible causes such as genetic or hormonal factors.

Globally, approximately 162 million children under the age of 5 have short stature [2]. In Indonesia, this prevalence in 2022 was 21.6% based on data from the Indonesian Nutrition Status Survey (SSGI), with an incidence of 25.0% in the Bandung district, ranking fifth in West Java [3]. In working towards achieving the goals of sustainable development, the Indonesian government is working to reduce these figures [2,4,5,6,7].

The short stature that occurs in the first 1000 days of life is caused by various factors, including micronutrient deficiencies such as vitamin D [1,4]. While micronutrient deficiencies such as vitamin D have gained attention as contributors, other factors: such as chronic infections, maternal malnutrition, low birth weight, and suboptimal feeding practices: also play significant roles in impairing linear growth [1,4,5,6]. Socio-economic disparities further compound these issues, limiting access to adequate healthcare and nutrition.

Vitamin D is a fat-soluble micronutrient that functions in the intestinal absorption of calcium and is believed to play a role in the growth of children. Vitamin D deficiency can have short-term and long-term effects. Vitamin D can affect the nervous system, and it has a role in the skeletal system. Vitamin D plays a role in brain health from the womb to old age [7]. Vitamin D receptors and 1α hydroxylase are located in neuronal and glial cells, in the nucleus and cytoplasm, and in the cingulate gyrus, caudate, putamen, and substantia nigra [8].

In vitro studies have shown that vitamin D has various actions on oligodendrocytes, astrocytes, microglia, and neuronal cells [8]. Vitamin D-deficient pregnancies can lead to premature birth, low birth weight, and hypoxic brain injury [9].

The prevalence of vitamin D deficiency in Asia is approximately 70%, varying between 6 and 70% in Southeast Asia, >50% in Indonesia, and 47 to 75% in Malaysia [7,8,9,10]. Children (neonates, preschool age) are often more at risk of vitamin D deficiency than adults [9,10,11,12]. The clinical manifestations of vitamin D deficiency are highly variable and even unknown [13,14,15,16,17,18,19,20].

Despite the potential link between vitamin D deficiency and short stature, findings across studies remain inconsistent. While research in Ecuador identified an association between low vitamin D levels and short stature in children aged 6 to 36 months, studies in Bangladesh found no significant differences in vitamin D levels among children with and without short stature [21,22,23,24]. These discrepancies underscore the need for further exploration of the multifactorial etiology of short stature and the role of vitamin D in developmental deviations.

Additionally, delays in developmental milestones, frequently seen in vitamin D-deficient children, may serve as early warning signs that require timely intervention.

2. Materials and Methods

This prospective cross-sectional study was conducted to evaluate the role of vitamin D in the developmental delays of children under two years of age with a history of stunted growth in Bandung Regency, West Java, Indonesia. The study targeted participants from the ALG research grant titled “The Role of Vitamin D in Reducing Maternal and Infant Mortality Rates Across Bandung Regency”. Children under 2 years of age with a height-for-age z-score (HAZ) < −2SD based on the WHO CGS curve were included.

Exclusion criteria included abnormal delivery processes, prematurity, low birth weight, history of seizures, multiple congenital anomalies, syndromic conditions, or chronic diseases and congenital anomalies that could affect growth and development, such as congenital heart defects and neurological disorders. Developmental status was assessed using the Indonesian standardized Prescreen Development Questionnaire (PSDQ), categorizing results as normal or abnormal. Ethical approval was obtained from the Research Ethics Committee of the Faculty of Medicine, Universitas Padjadjaran.

Serum samples were collected and analyzed to measure vitamin D levels using enzyme-linked immunosorbent assay (ELISA) kits. The stored biological samples, initially collected during the ALG study, were maintained at −80 °C. Vitamin D levels were categorized as deficient (<20 ng/mL), insufficient (21 to 29 ng/mL), or sufficient (>30 ng/mL). Developmental assessments were conducted in conjunction with laboratory analyses performed at the Clinical Pathology Laboratory of Dr. Hasan Sadikin General Hospital, Bandung.

The measurement of 25-hydroxyvitamin D [25(OH)D] was performed using the Euroimmun ELISA kit (Euroimmun AG, Lübeck, Germany). Serum samples were processed according to the manufacturer’s protocol, and absorbance was read at 405 nm using an ELISA reader (BioTek Instruments, Winooski, VT, USA). Sample size calculations were based on a 95% confidence level and 80% statistical power, resulting in a required minimum of 30 participants per group.

Before conducting statistical analyses, the normality of the data was assessed using the Shapiro: Wilk test to determine the appropriateness of parametric or non-parametric tests. Based on the results, the data in this study were not normally distributed. Descriptive statistics were used to summarize nutritional status and the prevalence of short stature. Comparisons of vitamin D levels between groups were made using the independent t-test for normally distributed data or the Mann: Whitney U-test for non-normally distributed data. Logistic regression was employed to assess the association between short stature and developmental deviations, with results expressed as odds ratios (ORs).

A p-value of <0.05 was considered statistically significant. All analyses were performed using SPSS version 24.

3. Results

A total of 221 children, consisting of 102 (46.2%) with short stature and 119 (53.8%) with normal stature, participated in this study. The characteristics of the subjects are shown in Table 1.

The median age of the short-stature group was significantly higher than that of the normal-stature group (19 months vs. 14 months, p < 0.001). The sex distribution in both groups was predominantly male. Mothers of short-stature children mainly had an education level of elementary or junior high school, while those of normal-stature children predominantly had a high school education or higher. Short-stature children were classified as underweight (21.6%), severely underweight (29.4%), or normal weight (49.0%), compared to normal-stature children, who were predominantly normal weight (91.6%), with only 7.6% underweight and 0.8% severely underweight.

Based on height-to-weight ratio, 12.7% and 10.8% of short-stature children were wasted and severely wasted, respectively, while 76.5% had normal ratios. In contrast, 87.4% of normal-stature children had normal ratios, with 10.1% wasted and 2.5% severely wasted. Head circumference was similar across groups.

Table 2 shows no significant differences in vitamin D levels (median 28.8 vs. 28.8, p = 0.555) or median age (17 vs. 12 months, p = 0.067) between short: and normal-stature children. Nutritional status based on BB/U of children with PSDQ deviation in short children included 15.8% underweight, 15.8% severely underweight, and 68.4% normal, compared to 93.5% normal in children of normal stature, with only 3.2% underweight and severely underweight. Height-for-age ratios showed 22.2% stunted, 29.9% severely stunted, and 48.9% normal among short children, while normal PSDQ children had 83.9% normal, 12.9% stunted, and 3.2% severely stunted.

PSDQ screening gave body weight and head circumference similar to age.

Table 3 shows higher deviations in children with short stature than in children with normal stature (95.1% vs. 78.2%, p < 0.001). However, there was no difference in vitamin D levels between children with different PSDQ scores (median 28.8 vs. 29.9, p = 0.4313). Likewise, there was no difference in the proportion of children who experienced vitamin D deficiency, insufficiency, or normal levels (86.7% vs. 86.2% vs. 85.6%, p = 0.985).

The logistic regression analysis in Table 4 showed that children with short stature have an increased risk of deviations of 5.46 times compared to those with normal stature. However, vitamin D had no effect on the incidence of PSDQ deviations.

4. Discussion

The study identified 102/221 (46.1%) children of short stature with mothers with lower education levels than those of children of normal height. This is similar to a study that revealed that maternal education was correlated with children of short stature in Indonesia [6]. Thus, more effort is needed from the government to improve education for mothers.

Anthropometric measures of short children revealed some underweight, severely underweight, and stunted children. Macronutrient and micronutrient deficiencies leading to lower body weight may also negatively impact height. A study in Malaysia found that 78.6% of children under 5 years of age were underweight. This can be influenced by lack of parental education, maternal nutrition, number of children, poverty, access to health facilities, and differences in conditions between cities and districts [25,26,27,28,29,30].

Vitamin D is a fat-soluble micronutrient that functions in the intestinal absorption of calcium and is believed to play a role in the growth of children. Vitamin D deficiency has been widely reported worldwide; however, the trends are inconsistent. Research in Bangladesh did not show differences in vitamin D levels in children with or without short stature [21]. However, vitamin D was associated with short stature in children aged 6 to 36 months in Ecuador [22].

Meanwhile, in India, vitamin D supplementation in children with short strides in India increased child growth [22,23].

In our study, there were no differences in vitamin D levels in both groups. However, vitamin D deficiency and insufficiency were found. Although Indonesia has sun exposure that provides sufficient vitamin D, some children experience vitamin D deficiency. Vitamin D exposure must be increased through outdoor play between 10:00 and 13:00 without the use of head covers or sunscreen and allowing more limbs to be exposed to sunlight.

Vitamin D deficiency can have short-term and long-term effects. Vitamin D can affect the nervous system and its role in the skeletal system. Vitamin D plays a role in brain health from the womb to old age [31]. Vitamin D receptors and 1α hydroxylase are located in neuronal and glial cells, in the nucleus and cytoplasm, and in the cingulate gyrus, caudate, putamen, and substantia nigra [30]. In vitro studies have shown that vitamin D has various actions on oligodendrocytes, astrocytes, microglia, and neuronal cells [32].

Vitamin D-deficient pregnancies can lead to premature birth, low birth weight, and hypoxic brain injury [32].

The biological pathways of vitamin D demonstrate several functions in the central nervous system, such as increasing brain cell differentiation, neurotrophin expression, neurotransmitter synthesis, intracellular calcium signaling, and gene/protein expression related to neuron structure. Research in rats born with vitamin D deficiency has shown anatomical changes in the brain, with an expanded cortex area (30%) and decreased ventricular volume, indicating a distortion in early brain development [31].

According to the recommendations of the American Academy of Pediatrics (AAP), developmental screening should be performed regularly, especially at the ages of 9, 18, and 30 months [33,34]. The PSDQ developed in Indonesia has good sensitivity and specificity and was therefore used to link short stature and vitamin D levels.

This study showed that developmental deviations were more prevalent among short children (95.1% vs. 78.2%, p < 0.001). There was no difference in vitamin D in the development deviation group. The relationship between vitamin D and developmental deviations has been studied, but the results are inconsistent. A delay in developmental milestones may be one of the early symptoms that accompany vitamin D deficiency [35]. Fetal vitamin D can affect brain development, as determined by the use of ASQ at 6 months, 12 months, and 24 months of age [26].

Vitamin D administration is also positively associated with temperament, language, and behavior but negatively associated with cognitive and motor impairment [21]. Vitamin D deficiency during the first trimester increases the risk of motor delays by 1 year of age [27]. On the other hand, growth or development in children with vitamin D deficiency has not shown clear differences [28]. In this study, logistic regression analysis showed that short children have a 5.46 times higher risk of developmental deviations.

5. Conclusions

Short stature remains a problem in the Bandung district of Indonesia. Although vitamin D levels do not affect height and developmental deviations, short children are more likely to be underweight and wasted, with a higher incidence of developmental deviations. It should be noted that one of the limitations of this study is that it did not analyze other factors affecting growth or children experiencing developmental deviations such as parenting, diet, genetic factors, and other nutritional elements such as calcium and phosphorus.

Therefore, further research is warranted on the relationship between vitamin D and short stature and developmental deviations.

Acknowledgments

The authors would like to thank all the participants in this study for their valuable contributions and participation.

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Author Contributions

Conceptualization, methodology, software, validation, formal analysis, investigation, resources, data curation, writing: original draft, writing: review and editing, visualization, supervision, project administration, and funding acquisition: M.M.D.; writing: review and editing: A.I., N.A.R., G.M.P. and R.T.D.J.; supervision: B.S. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board (Ethics Committee) of Universitas Padjadjaran, Bandung (959/UN6.KEP/EC/2021, 18 November 2021).

Informed Consent Statement

Informed consent was obtained from the parents or guardians of all child participants involved in this study.

Data Availability Statement

The original data used to support the findings of this study are available upon request from the corresponding author due to ethical reasons.

Conflicts of Interest

The authors declare no conflicts of interest.

References

1. World Health Organization Global Nutrition Targets 2025 Stunting Policy Brief PhysicsWeb2018 Available online: https://www.who.int/publications/i/item/WHO-NMH-NHD-14.3(accessed on 15 February 2024)
2. Ministry of Health of the Republic Indonesia Regulation of the Minister of Health of the Republic Number 66 of 2014 Concerning Monitoring Growth, Development and Developmental Disorders of Children PhysicsWeb2014 Available online: https://peraturan.go.id/id/permenkes-no-66-tahun-2014(accessed on 15 February 2024)
3. Hasil Survei Status Gizi Indonesia (SSGI) 2022 Ministry of Health of the Republic IndonesiaJakarta, Indonesia2022
4. Jena D. Syena F. Fahmida T. Integrating An Early Childhood Development Programme Into Bangladeshi Primary Health-Care Services: An Open-Label, Cluster-Randomised Controlled Trial Lancet Glob. Health 2019 7 366 375 10.1016/S2214-109X(18)30535-7 30784637
5. Ministry of Health of the Republic Indonesia Indonesian Basic Health Research 2013 National Institute of Health Research and Development Indonesian MinistryJakarta, Indonesia2013
6. Beal T. Tumilowicz A. Sutrisna A. Izwardy D. Neufeld L.M. A review of child stunting determinants in Indonesia Matern. Child. Nutr. 2018 14 e12617 10.1111/mcn.12617 29770565 PMC6175423
7. Hossein-nezhad A. Holick M.F. Vitamin D for health: A global perspective Mayo Clinic Proceedings ElsevierAmsterdam, The Netherlands2013 720 755 10.1016/j.mayocp.2013.05.011 PMC3761874 23790560
8. Poh B.K. Rojroongwasinkul N. Le Nguyen B.K. Ruzita A.T. Yamborisut U. Hong T.N. Ernawati F. Deurenberg P. Parikh P. SEANUTS Study Group 25-hydroxy-vitamin D demography and the risk of vitamin D insufficiency in the South East Asian Nutrition Surveys (SEANUTS) Asia Pac. J. Clin. Nutr. 2016 25 538 548 27440689 10.6133/apjcn.092015.02
9. Sari D.K. Tala Z.Z. Lestari S. Hutagalung S. Ganie R.A. Vitamin D receptor gene polymorphism among Indonesian women in North Sumatera Asian J. Clin. Nutr. 2017 9 44 50
10. Quah S.W. Abdul Majid H. Al-Sadat N. Yahya A. Su T.T. Jalaludin M.Y. Risk factors of vitamin D deficiency among 15-year-old adolescents participating in the Malaysian Health and Adolescents Longitudinal Research Team Study (MyHeARTs) PLoS ONE 2018 13 e0200736 10.1371/journal.pone.0200736 30024934 PMC6053195
11. Nimitphong H. Holick M.F. Vitamin D status and sun exposure in Southeast Asia Dermato-endocrinology 2013 5 34 37 10.4161/derm.24054 24494040 PMC3897596
12. Arabi A. El Rassi R. Fuleihan G.E.-H. Hypovitaminosis D in developing countries: Prevalence, risk factors and outcomes Nat. Rev. Endocrinol. 2010 6 550 10.1038/nrendo.2010.146 20852586
13. Guo Y. Ke H.J. Liu Y. Fu M. Ning J. Yu L.I. Xiao Y.U. Che D.I. Chen X.Y. Deng Y.H. Prevalence of vitamin D insufficiency among children in southern china: A cross-sectional survey Medicine 2018 97 e11030 10.1097/MD.0000000000011030 29923990 PMC6023856
14. Togo A. Maciá D.E. Segura S.B. Díaz N.S. Martínez C.V. Is there vitamin D deficiency in children in a sunny Mediterranean city? An. Pediatría 2016 84 163 169 10.1016/j.anpedi.2015.05.003 26058340
15. Basatemur E. Horsfall L. Marston L. Rait G. Sutcliffe A. Trends in the diagnosis of vitamin D deficiency Pediatrics 2017 139 e20162748 10.1542/peds.2016-2748 28159871 PMC5337117
16. Fasih Z Evaluating the frequency of vitamin D deficiency in the pediatric age group and identifying the biochemical predictors associated with vitamin D deficiency Pediatr. Ther. 2016 6 665 2161
17. Isa H. Almaliki M. Alsabea A. Mohamed A. Vitamin D deficiency in healthy children in Bahrain: Do gender and age matter? East. Mediterr. Heal. J. 2020 26 260 267 10.26719/emhj.19.084 32281634
18. Saggese G. Vierucci F. Prodam F. Cardinale F. Cetin I. Chiappini E. De’Angelis G.L. Massari M. Miraglia Del Giudice E.M. Del Giudice M.M. Vitamin D in pediatric age: Consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians Ital. J. Pediatr. 2018 44 1 40 10.1186/s13052-018-0488-7 29739471 PMC5941617
19. Ernawati F. Budiman B. Status vitamin D terkini anak indonesia usia 2, 0 to 12, 9 Tahun Gizi Indones. 2015 38 73 80 10.36457/gizindo.v38i1.169
20. Sandjaja S. Budiman B. Harahap H. Ernawati F. Soekatri M. Widodo Y. Sumedi E. Rustan E. Sofia G. Syarief S.N. Food consumption and nutritional and biochemical status of 0·5 to 12-year-old Indonesian children: The SEANUTS study Br. J. Nutr. 2013 110 S11 S20 10.1017/S0007114513002109 24016762
21. Tofail F. Islam M.M. Mahfuz M. Alam M.A. Aktar S. Haque R. Hossain M.I. Mondal D. Petri W.A. Ahmed T. Association of vitamin D nutrition with neuro-developmental outcome of infants of slums in Bangladesh PLoS ONE 2019 14 e0221805 10.1371/journal.pone.0221805 31557172 PMC6762070
22. Mokhtar R.R. Holick M.F. Sempértegui F. Griffiths J.K. Estrella B. Moore L.L. Fox M.P. Hamer D.H. Vitamin D status is associated with underweight and stunting in children aged 6 to 36 months residing in the Ecuadorian Andes Public Health Nutr. 2018 21 1974 1985 10.1017/S1368980017002816 29162164 PMC10260858
23. Stewart C.P. Iannotti L. Dewey K.G. Michaelsen K.F. Onyango A.W. Contextualising complementary feeding in a broader framework for stunting prevention Matern. Child. Nutr. 2013 9 27 45 10.1111/mcn.12088 24074316 PMC6860787
24. Mugunthan S.R. Rao Y.K. Midha T. Bajpai A. Effect of vitamin D supplementation on growth parameters of children with vitamin D deficiency: A community based randomized controlled trial Int. J. Contemp. Pediatr. 2017 4 2070 2074 10.18203/2349-3291.ijcp20174733
25. Ahmed S.F. Franey C. McDevitt H. Somerville L. Butler S. Galloway P. Reynolds L. Shaikh M.G. Wallace A.M. Recent trends and clinical features of childhood vitamin D deficiency presenting to a children’s hospital in Glasgow Arch. Dis. Child. 2011 96 694 696 10.1136/adc.2009.173195 20584848
26. Yates N.J. Tesic D. Feindel K.W. Smith J.T. Clarke M.W. Wale C. Crew R.C. Wharfe M.D. O Whitehouse A.J. Wyrwoll C.S. Vitamin D is crucial for maternal care and offspring social behaviour in rats J. Endocrinol. 2018 237 73 85 10.1530/JOE-18-0008 29559544
27. Supriadi S. Gumilang L. Setiabudi D. Dewi R.T. Setiabudiawan B. Dhamayanti M. Cord blood vitamin D is correlated with problem solving domain in early childhood neurodevelopment: A Cohort Study on Vitamin D Status and Its Impact during Pregnancy and Childhood in Indonesia Res. Sq. 2020 10.21203/rs.3.rs-18033/v1
28. Dhamayanti M. Noviandhari A. Supriadi S. Judistiani R.T.D. Setiabudiawan B. Association of maternal vitamin D deficiency and infants’ neurodevelopmental status: A cohort study on vitamin D and its impact during pregnancy and childhood in Indonesia J. Paediatr. Child. Health 2020 56 16 21 10.1111/jpc.14481 31062441
29. Chowdhury R. Taneja S. Bhandari N. Kvestad I. Strand T.A. Bhan M.K. Vitamin-D status and neurodevelopment and growth in young north Indian children: A secondary data analysis Nutr. J. 2017 16 1 8 10.1186/s12937-017-0285-y 28923060 PMC5604419
30. Salleh R. Ahmadz M.H. Man C.S. Wong N.I. Sallehuddin S.M. Palanivelo L. Risk Factors Associated with Underweight Children Under the Age of Five in Putrajaya, Malaysia: A Case-Control Study J. Gizi Pangan 2023 18 89 98 10.25182/jgp.2023.18.2.89-98
31. Amaral A.D. Calhau C. Coelho R. Schizophrenia: Implications of vitamin D deficiency on brain development Int. J. Clin. Neurosci. Ment. Health 2014 1 1 14
32. Eyles D. McGrath J. Vitamin D Brain Development and Function 4th ed. Hewison M. Bouillon R. Giovannucci E. Goltzman D. Meyer M. Welsh J. ElsevierChatswood, Australia2018 563 581
33. Anjum I. Jaffery S.S. Fayyaz M. Samoo Z. Anjum S. The role of vitamin D in brain health: A mini literature review Cureus 2018 10 e2960 10.7759/cureus.2960 30214848 PMC6132681
34. Lipkin P.H. Macias M.M. Promoting optimal development: Identifying infants and young children with developmental disorders through developmental surveillance and screening Pediatrics 2020 145 e20193449 10.1542/peds.2019-3449 31843861
35. Abdulmoein Aagha E. Abushanab R.H. Balto H.M. Alahdal D.M. Clinical Presentations of Vitamin D Deficiency in Children at King Abdul-Aziz University Hospital, Jeddah, Saudi Arabia: A Cross-Sectional Survey Gen. Med. 2016 4 2
Table 1

Characteristics of short and normal stature children.

VariableShort Stature
n = 102
Normal Stature
n = 119
p
Age (Month)
Median (IQR)19 (15 to 22)14 (9 to 20)<0.001 a*
Sex
Male61 (59.8)63 (52.9)0.305 b
Female41 (40.2)56 (47.1)
Mother’s Education
Elementary41 (40.2)31 (26.1)0.010 b*
Junior high school43 (42.2)47 (39.5)
Senior high school18 (17.6)41 (34.5)
Mother’s Occupation
Housewife90 (88.2)111 (93.3)0.193 b
Working12 (11.8)8 (6.7)
Socio-economic status
Minimum wage5 (4.9)5 (4.2)0.590 b
Below 87 (85.3)97 (81.5)
Above10 (9.8)17 (14.3)
Body weight/age
Normal50 (49.0)109 (91.6)<0.001 b*
Underweight22 (21.6)9 (7.6)
Severely underweight30 (29.4)1 (0.8)
Nutritional Status (weight/height)
Normal78 (76.5)104 (87.4)0.029 b*
Wasted13 (12.7)12 (10.1)
Severely wasted11 (10.8)3 (2.5)
Head Circumference
Normal75 (73.5)84 (70.6)0.200 b
Microcephaly23 (22.5)23 (19.3)
Macrocephaly4 (3.9)12 (10.1)

Note: a Mann: Whitney test, b Chi-square test, * significant difference.

Table 2

Differences in vitamin D levels between children of short stature and normal height.

VariableShort Stature
n = 102
Normal Stature
n = 119
p
Vitamin D
Median (IQR)28.8 (23.6 to 32.5)28.8 (22.8 to 36.2)0.555 a
Vitamin D
Deficiency12 (11.8)18 (15.1)0.647 b
Insufficiency43 (42.1)44 (37.0)
Normal47 (46.1)57 (47.9)

Note: a Mann: Whitney test, b Chi-square test.

Table 3

Characteristics of Prescreen Development Questionnaire (PSDQ) for child development.

VariablePSDQ p
Deviation/Doubtful
n = 190
Normal
n = 30
Age (month)
Median (IQR)17 (12 to 21)12 (9 to 20)0.067 a
Sex
Male106 (55.8)18 (58.1)0.813 b
Female84 (44.2)13 (41.9)
Mother’s Education
Elementary school65 (34.2)7 (22.6)0.213 b
Junior high school78 (41.1)12 (38.7)
Senior high school47 (24.7)12 (38.7)
Mother’s Occupation
Housewife171 (90.0)30 (96.8)0.322 b
Working19 (10.0)1 (3.2)
Socio-economic status
According to regional minimum wage9 (4.8)1 (3.2)0.160 b
Below regional minimum wage161 (84.7)23 (74.2)
Above regional minimum wage20 (10.5)7 (22.6)
Body Weight/Age
Normal130 (68.4)29 (93.5)0.015 b*
Underweight30 (15.8)1 (3.2)
Severely underweight30 (15.8)1 (3.2)
Height/Age
Normal93 (48.9)26 (83.9)0.001 b*
Stunted42 (22.2)4 (12.9)
Severely stunted55 (29.9)1 (3.2)
Nutrition State BB/TB
Normal153 (80.6)29 (93.6)0.204 b
Wasted24 (12.6)1 (3.2)
Severely wasted13 (6.8)1 (3.2)
Head Circumference/Age
Normal135 (71.1)24 (77.4)0.610 b
Microsefal40 (21.0)6 (19.4)
Macrosefal15 (7.9)1 (3.2)

Note: a Mann: Whitney test, b Chi-square test, * significant difference.

Table 4

Relationship between short stature, vitamin D, and child development according to logistic regression analysis.

VariableTotalPSDQ p UnivariateMultivariate
n = 221Deviation/DoubtfulNormalOR (95% CI)Nilai pAdjusted OR
(95% CI)
p
n = 190n = 31
Stature
Short10297 (95.1)5 (4.9)<0.001 b*5.42 (2.00 to 14.72)0.001 *5.46 (2.01 to 14.84)0.001 *
Normal11993 (78.2)26 (21.8) 1 1
Vitamin D
Median (IQR) 28.8 (22.975 to 34.6)29.9 (25.3 to 35.3)0.413 a
Vitamin D
Deficiency3026 (86.7)4 (13.3)0.985 b1.10 (0.34 to 3.59)0.881.19 (0.35 to 4.01)0.784
Insufficiency8775 (86.2)12 (13.8) 1.05 (0.46 to 2.39)0.9010.99 (0.43 to 2.31)0.983
Normal10489 (85.6)15 (14.4) 1 1

Note: a Mann: Whitney test, b Chi-square test, * significant difference. Dependent variable: Development deviation, OR = odds ratio, CI = confidence interval.

Publication and source details

Original title: Association Between Vitamin D Levels and Developmental Status in Short-Stature Children

Mia Milanti Dewi; Akhmad Imron; Nelly Amalia Risan; Grace Mediana Purnami; Raden Tina Dewi Judistiani; Budi Setiabudiawan

Children · 2024

* Correspondence: mia.milanti@unpad.ac.id© 2024 by the authors.2024https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Hibah Internal Unpad1595/UN6.3.1/PT.00/202University of PadjadjaranThis study was supported in part by the Hibah Internal Unpad Grant id 1595/UN6.3.1/PT.00/202 from the University of Padjadjaran (awarded to Budi Setiabudiawan).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T03:05:46.529570+00:00

DOI: 10.3390/children11121542 · PMC11727358